Elizabeth B. Andrews, MPH, PhD, F.I.S.P.E.
Vice President, Pharmacoepidemiology and Risk Management, RTI Health Solutions
Joseph M. Feczko, M.D.
Board of Directors, Foundation for the National Institutes of Health
Retired Senior Vice President and Chief Medical Officer, Pfizer, Inc.
Jesse L. Goodman, MD, MPH
Chief Scientist and Deputy Commissioner (Acting) for Science and Public Health, Food and Drug Administration
Steven J. Jacobsen, MD, PhD
Director of Research, Kaiser Permanente Southern California
Sangtae Kim, PhD
Director of Pharmaceutical Informatics, University of Wisconsin-Madison
Ronald L. Krall, MD
Former Senior Vice-President and Chief Medical Officer, GlaxoSmithKline
Richard Platt, MD, MSc
Professor and Chair of the Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care
N. Lee Rucker, M.S.P.H.
Senior Strategic Policy Advisor, AARP Public Policy Institute.
Brian L. Strom, MD, MPH
George S. Pepper Professor of Public Health and Preventive Medicine
Professor of Biostatistics and Epidemiology, Medicine, and Pharmacology
Chair, Department of Biostatistics and Epidemiology
Director, Center for Clinical Epidemiology and Biostatistics
Vice Dean for Institutional Affairs, University of Pennsylvania School of Medicine
Senior Advisor to the Provost for Global Health Initiatives, University of Pennsylvania
President, National Health Council
Marcus D. Wilson, Pharm.D.
Janet Woodcock, MD
Director, Center for Drug Evaluation and Research, Food and Drug Administration
OMOP Executive Board Chairperson
SCIENTIFIC ADVISORY BOARD:
The Scientific Advisory Board (SAB) provides independent review of and expert input into the scientific aspects of OMOP’s activities.
Andrew Bate, PhD
Pfizer, Senior Director, Quantitative Epidemiologist
Dr. Jesse Berlin
Johnson & Johnson Pharmaceutical R & D, Vice President, Epidemiology
Michael S. Katz
International Myeloma Foundation; Coalition of Cancer Cooperative Groups, Vice President; Chair, Patient Advisory Board
Dr. David Page
University of Wisconsin – Madison, Professor, Department of Biostatistics & Medical Informatics
Judith A. Racoosin, MD, MPH
Deputy Director for Safety
Division of Anesthesia, Analgesia, and Addiction Products, Center for Drug Evaluation and Research, FDA
Kenneth J. Rothman, DrPH
RTI Health Solutions, RTI International, Research Triangle Park, NC, Distinguished Fellow and Vice President, Epidemiology Research; Boston University, Boston, MA, Professor of Epidemiology and Medicine
Judy A. Staffa, PhD, R.Ph
FDA/CDER/OSE, Associate Director for Regulatory Research
HEALTH INFORMATICS ADVISORY BOARD:
The Health Informatics Advisory Board (HIAB) provides independent review and expert input into the OMOP’s technology efforts related to privacy and security, terminology and coding, data, and data models.
Stanley M. Huff, MD
Intermountain Healthcare; University of Utah School of Medicine, Chief Medical Informatics Officer; Professor (clinical)
Diane T. MacKinnon
FDA (CDER), Patient Consultant
Dr. Clement J. McDonald
Director, Lister Hill Center for Biomedical Communications
Associate Director, Medical Informatics
Food and Drug Administration